TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. By Cancer History Project November 7, 2003
TCL Archive Also STAR trial can be completed with fewer women than planned, NSABP says. By Cancer History Project November 7, 2003
TCL Archive NCCF, Ad Council plan public service ads on childhood cancer. By Cancer History Project November 7, 2003
TCL Archive MSKCC hopes to raise $1 billion in five-year campaign. By Cancer History Project November 7, 2003
TCL Archive NCI director apologizes to cancer centers for inaction on working group report. By Cancer History Project October 31, 2003
TCL Archive Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds By Cancer History Project October 31, 2003
TCL Archive Novel Antifungal Agent Highly Active Against Esophageal Candidiasis By Cancer History Project October 31, 2003
TCL Archive Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs. By Cancer History Project October 31, 2003